VAXIMM
Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinical trials in 2011.
VAXIMM
Industry:
Biotechnology Developer Platform Therapeutics
Founded:
2008-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.vaximm.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Euro
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioMedPartners
BioMedPartners investment in Venture Round - VAXIMM
BB Biotech Ventures
BB Biotech Ventures investment in Venture Round - VAXIMM
Merck
Merck investment in Venture Round - VAXIMM
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Venture Round - VAXIMM
Official Site Inspections
http://www.vaximm.com Semrush global rank: 5.45 M Semrush visits lastest month: 1.56 K
- Host name: 217-160-0-40.elastic-ssl.ui-r.com
- IP address: 217.160.0.40
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
